| |
| |
|
| Insider
Information: |
Bishop John E |
| Relationship: |
SVP, Chief Technology ... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
157,253 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,252,637 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
157,253 |
|
|
| Total
Value |
$8,252,637 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
Senior VP, Pharmaceuti... |
2016-05-19 |
157,253 |
2006-02-17 |
0 |
Premium* |
|
|
Forma Therapeutics Holdings, Inc., |
FMTX |
SVP, Chief Technology ... |
2022-10-14 |
0 |
2021-06-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
167 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2009-09-15 |
4 |
AS |
$10.54 |
$3,141 |
D/D |
(298) |
43,047 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2009-11-23 |
4 |
AS |
$10.49 |
$2,832 |
D/D |
(270) |
42,777 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2009-12-14 |
4 |
AS |
$11.09 |
$4,159 |
D/D |
(375) |
42,402 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2009-12-15 |
4 |
AS |
$11.16 |
$3,370 |
D/D |
(302) |
42,100 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-01-25 |
4 |
AS |
$14.98 |
$261,895 |
D/D |
(17,483) |
42,100 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,450 |
52,546 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-02-22 |
4 |
AS |
$15.45 |
$38,579 |
D/D |
(2,497) |
53,049 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-02-23 |
4 |
AS |
$15.09 |
$4,557 |
D/D |
(302) |
52,747 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-03-01 |
4 |
AS |
$14.65 |
$16,891 |
D/D |
(1,153) |
51,594 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-03-17 |
4 |
AS |
$14.59 |
$8,637 |
D/D |
(592) |
51,002 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-05-25 |
4 |
AS |
$11.56 |
$3,630 |
D/D |
(314) |
50,688 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-05-26 |
4 |
AS |
$12.45 |
$3,536 |
D/D |
(284) |
50,404 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-06-15 |
4 |
AS |
$14.00 |
$5,964 |
D/D |
(426) |
49,978 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-06-16 |
4 |
AS |
$13.69 |
$5,873 |
D/D |
(429) |
49,549 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-06-17 |
4 |
AS |
$14.88 |
$37,170 |
D/D |
(2,498) |
49,549 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-07-23 |
4 |
AS |
$20.77 |
$1,411,206 |
D/D |
(67,950) |
49,549 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-08-23 |
4 |
AS |
$16.08 |
$40,168 |
D/D |
(2,498) |
49,549 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-08-24 |
4 |
AS |
$15.22 |
$4,718 |
D/D |
(310) |
49,239 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-08-26 |
4 |
AS |
$16.57 |
$4,706 |
D/D |
(284) |
48,955 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-09-15 |
4 |
AS |
$15.51 |
$6,607 |
D/D |
(426) |
48,529 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-09-16 |
4 |
AS |
$15.10 |
$6,433 |
D/D |
(426) |
48,103 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-11-22 |
4 |
AS |
$15.32 |
$38,269 |
D/D |
(2,498) |
48,103 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-11-23 |
4 |
AS |
$15.20 |
$4,697 |
D/D |
(309) |
47,794 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-11-29 |
4 |
AS |
$15.22 |
$4,338 |
D/D |
(285) |
47,509 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-12-15 |
4 |
AS |
$14.42 |
$6,143 |
D/D |
(426) |
47,083 |
0 |
- |
|
167 Records found
|
|
Page 2 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
